Literature DB >> 29414014

Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.

Michele Protti1, Maria Carmen Catapano2, Boaz Gedaliahu Samolsky Dekel3, James Rudge4, Gilberto Gerra5, Lorenzo Somaini6, Roberto Mandrioli7, Laura Mercolini8.   

Abstract

Oxycodone is a widely prescribed, full agonist opioid analgesic. As such, it is used clinically to treat different kinds of painful conditions, with a relatively high potential for doping practices in athletes. In this paper, different classic and innovative miniaturised matrices from blood and urine have been studied and compared, to evaluate their relative merits and drawbacks within therapeutic drug monitoring (TDM) and to implement new protocols for anti-doping analysis. Plasma, dried blood spots (DBS) and dried plasma spots (DPS) have been studied for TDM purposes, while urine, dried urine spots (DUS) and volumetric absorptive microsamples (VAMS) from urine for anti-doping. These sampling techniques were coupled to an original bioanalytical method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the evaluation and monitoring of the levels of oxycodone and its major metabolites (noroxycodone and oxymorphone) in patients under pain management and in athletes. The method was validated according to international guidelines, with good results in terms of precision, extraction yield and accuracy for all considered micromatrices. Thus, the proposed sampling, pre-treatment and analysis are attractive strategies for oxycodone determination in human blood and urine, with advanced options for application to derived micromatrices. Microsampling procedures have significant advantages over classic biological matrices like simplified sampling, storage and processing, but also in terms of precision (<9.0% for DBS, <7.7% for DPS, <7.1% for DUS, <5.3% for VAMS) and accuracy (>73% for DBS, >78% for DPS, >74% for DUS, >78% for VAMS). As regards extraction yield, traditional and miniaturised sampling approaches are comparable (>67% for DBS, >74% for DPS, >75% for DUS, >75% for VAMS). All dried matrices have very low volumes, leading to a significant advantage in terms of analysis feasibility. On the other hand, this also leads to a corresponding decrease in the overall sensitivity.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-doping analysis; Bioanalysis; Blood and urine microsamples; Oxycodone; Therapeutic drug monitoring; Volumetric absorptive microsampling

Mesh:

Substances:

Year:  2018        PMID: 29414014     DOI: 10.1016/j.jpba.2018.01.043

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  12 in total

1.  Pharmacokinetics of Albendazole, Albendazole Sulfoxide, and Albendazole Sulfone Determined from Plasma, Blood, Dried-Blood Spots, and Mitra Samples of Hookworm-Infected Adolescents.

Authors:  Jessica D Schulz; Anna Neodo; Jean T Coulibaly; Jennifer Keiser
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers.

Authors:  Michele Protti; Marco Cirrincione; Roberto Mandrioli; James Rudge; Luca Regazzoni; Valeria Valsecchi; Claudia Volpi; Laura Mercolini
Journal:  Molecules       Date:  2022-09-01       Impact factor: 4.927

3.  Volumetric Absorptive Microsampling of Blood for Untargeted Lipidomics.

Authors:  Camilla Marasca; Maria Encarnacion Blanco Arana; Michele Protti; Andrea Cavalli; Laura Mercolini; Andrea Armirotti
Journal:  Molecules       Date:  2021-01-07       Impact factor: 4.411

4.  Development, validation, and application of a quantitative volumetric absorptive microsampling-based method in finger prick blood by means of LC-HRMS/MS applicable for adherence monitoring of antipsychotics.

Authors:  Cathy M Jacobs; Lea Wagmann; Markus R Meyer
Journal:  Anal Bioanal Chem       Date:  2021-01-30       Impact factor: 4.142

Review 5.  Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review.

Authors:  Yahdiana Harahap; Rasmina Diptasaadya; Denni Joko Purwanto
Journal:  Drug Des Devel Ther       Date:  2020-12-31       Impact factor: 4.162

6.  A high-throughput bioanalytical assay to support pharmacokinetic interaction study of oxycodone and diazepam in Sprague Dawley rats.

Authors:  Nageswara R Pilli; Suresh Narayanasamy; Lin Xu; Ashok Chockalingam; Katherine I Shea; Sharron Stewart; Rodney Rouse; Vikram Patel; Murali K Matta
Journal:  RSC Adv       Date:  2020-01-03       Impact factor: 4.036

7.  Dried Urine Microsampling Coupled to Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) for the Analysis of Unconjugated Anabolic Androgenic Steroids.

Authors:  Michele Protti; Camilla Marasca; Marco Cirrincione; Angelo E Sberna; Roberto Mandrioli; Laura Mercolini
Journal:  Molecules       Date:  2020-07-14       Impact factor: 4.411

8.  Blood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine Consumption.

Authors:  Roberto Mandrioli; Laura Mercolini; Michele Protti
Journal:  Molecules       Date:  2020-02-26       Impact factor: 4.411

9.  Electrochemical Detection of Oxycodone and Its Main Metabolites with Nafion-Coated Single-Walled Carbon Nanotube Electrodes.

Authors:  Elsi Mynttinen; Niklas Wester; Tuomas Lilius; Eija Kalso; Bjørn Mikladal; Ilkka Varjos; Sami Sainio; Hua Jiang; Esko I Kauppinen; Jari Koskinen; Tomi Laurila
Journal:  Anal Chem       Date:  2020-05-28       Impact factor: 6.986

10.  The Quantification of Oxycodone and Its Phase I and II Metabolites in Urine.

Authors:  Michael T Truver; Gerd Jakobsson; Maria D Chermà; Madeleine J Swortwood; Henrik Gréen; Robert Kronstrand
Journal:  J Anal Toxicol       Date:  2022-02-14       Impact factor: 3.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.